Skip to content

Adipocare 2025: Insights on GLP-1 Therapy and Obesity Management

Laketown Synergy, in association with Woodlands Multispeciality Hospital, was pleased to host the Adipocare 2025 symposium on Saturday, September 6th, at The Park Hotel in Kolkata. The event provided a dedicated forum for local medical professionals to engage with the latest advancements in diabetes and obesity care, reinforcing our commitment to raising awareness and exploring practical strategies for lifelong disease management.

A Detailed Review of the Clinical Discussions

The agenda featured a series of in-depth presentations designed to translate clinical evidence into practice.

  • Context Setting by Dr. Soumyabrata Roy Chaudhuri
    As chairperson, Dr. Soumyabrata Roy Chaudhuri expertly framed the contemporary challenges in diabetes management, emphasizing the need for a holistic approach that addresses the disease throughout a patient’s life.
  • GLP-1 and Cardiovascular Wellness by Dr. Biswajit Ghoshdostidar
    Dr. Biswajit Ghoshdostidar delivered an insightful presentation on the critical role of GLP-1 receptor agonists in promoting cardiovascular health. His analysis of key trial data highlighted their importance not only for glycemic control but as essential agents for long-term cardioprotection in diabetic patients.
  • Expanding Horizons of GLP-1 Therapy by Dr. Soumyabrata Roy Chaudhuri
    Building on this foundation, Dr. Roy Chaudhuri detailed the extensive benefits of GLP-1 therapies, which extend into weight management and overall metabolic improvement. His talk provided a comprehensive view of how these tools can significantly enhance patient quality of life. He concluded with an insightful comparison between semaglutide and tirzepatide across different indications and management outcomes, providing a balanced perspective based on published evidence.
  • Exploring the Role of Semaglutide 2.4 mg by Dr. Arundhati Dasgupta
    Dr. Dasgupta provided a rigorous examination of the Semaglutide 2.4 mg clinical trial data (STEP program), establishing its evidence-based role as a effective therapeutic option for obesity management, a key comorbidity of diabetes.
  • Panel Discussion: Breaking the Obesity Cycle
    Moderated by Dr. Soumyabrata Roy Chaudhuri, the panel featured Drs. Biswajit Ghoshdostidar and Manas Som. Dr. Arundhati Dasgupta was also called to the stage on an impromptu basis by the moderator, where she added significant value to the discussion with her sharp, evidence-based answers. The conversation focused on real-world strategies for implementing these therapies and supporting patients in sustainable long-term management.

Acknowledgements and Concluding Remarks

The success of this educational initiative was made possible through the generous support of our partners and the dedication of our esteemed faculty. Laketown Synergy, along with our co-organizer Woodlands Multispeciality Hospital, extends its sincere gratitude to the event’s sponsors and to Novo Nordisk for their supported session.

We are particularly thankful to our faculty—Drs. Soumyabrata Roy Chaudhuri, Biswajit Ghoshdostidar, Arundhati Dasgupta, and Manas Som—for sharing their valuable time and expertise to advance medical knowledge in our community.

The insights shared at Adipocare 2025 will undoubtedly contribute to enhanced patient care in Kolkata. We thank all attendees for their participation and invite the medical community to learn more about our ongoing educational efforts on our CME events page.